Table 1. Cell Marker Studies of the... | American Society of Hematology

Table 1.

Cell Marker Studies of the Patient's Tumor Cells and Cell Line

	Tumor Cells (%)	Cell Line (%)
CD1	0.1	0.7
CD2	0.5	0.8
CD3	0.0	0.0
CD4	0.2	3.8
CD5	0.1	0.2
CD7	0.3	1.0
CD8	0.2	0.5
CD10	89.3	96.1
CD13	0.2	1.2
CD14	0.0	0.1
CD19	55.1	95.5
CD20	19.6	68.5
CD33	0.3	0.4
HLA-DR	99.9	98.8
Surface Ig	— ^*	— ^*
Cytoplasmic Ig	— ^*	— ^*

	Tumor Cells (%)	Cell Line (%)
CD1	0.1	0.7
CD2	0.5	0.8
CD3	0.0	0.0
CD4	0.2	3.8
CD5	0.1	0.2
CD7	0.3	1.0
CD8	0.2	0.5
CD10	89.3	96.1
CD13	0.2	1.2
CD14	0.0	0.1
CD19	55.1	95.5
CD20	19.6	68.5
CD33	0.3	0.4
HLA-DR	99.9	98.8
Surface Ig	— ^*	— ^*
Cytoplasmic Ig	— ^*	— ^*

Neither light (κ, λ) nor heavy chains (γ, α, μ, δ) were detected.